CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$62,000
-46.1%
20,727
-19.1%
0.00%
Q4 2021$115,000
-4.2%
25,613
+3.9%
0.00%
Q3 2021$120,000
-72.2%
24,640
-61.0%
0.00%
-100.0%
Q2 2021$431,000
-7.5%
63,149
-4.3%
0.00%0.0%
Q1 2021$466,000
+12.8%
66,0020.0%0.00%0.0%
Q4 2020$413,000
+15.7%
66,0020.0%0.00%0.0%
Q3 2020$357,000
+11.2%
66,002
+7.3%
0.00%0.0%
Q2 2020$321,000
+103.2%
61,484
+22.6%
0.00%
Q1 2020$158,000
-21.0%
50,132
+1.2%
0.00%
Q4 2019$200,000
-6.5%
49,5470.0%0.00%
Q3 2019$214,000
+8.1%
49,5470.0%0.00%
Q2 2019$198,000
-25.6%
49,5470.0%0.00%
-100.0%
Q1 2019$266,000
+4.7%
49,5470.0%0.00%0.0%
Q4 2018$254,000
-45.7%
49,547
+2.8%
0.00%0.0%
Q3 2018$468,000
-4.9%
48,1980.0%0.00%0.0%
Q2 2018$492,000
-6.8%
48,198
+18.7%
0.00%0.0%
Q1 2018$528,000
-21.4%
40,617
+8.2%
0.00%0.0%
Q4 2017$672,000
-29.3%
37,532
-0.9%
0.00%
-50.0%
Q3 2017$951,000
-5.5%
37,889
-9.2%
0.00%0.0%
Q2 2017$1,006,000
+34.3%
41,722
+7.2%
0.00%0.0%
Q1 2017$749,000
+28.9%
38,922
+3.2%
0.00%
+100.0%
Q4 2016$581,000
+15.3%
37,722
-2.6%
0.00%0.0%
Q3 2016$504,000
+20.0%
38,722
+28.1%
0.00%0.0%
Q2 2016$420,000
+7.1%
30,222
+17.0%
0.00%0.0%
Q1 2016$392,000
-8.4%
25,836
+14.6%
0.00%0.0%
Q4 2015$428,000
+1.7%
22,549
+1.7%
0.00%0.0%
Q3 2015$421,000
-26.7%
22,169
-0.4%
0.00%0.0%
Q2 2015$574,00022,2690.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$36,172,00026.83%
Abingworth LLP 1,301,413$18,103,00018.96%
Roumell Asset Management, LLC 290,136$4,036,0009.16%
Monashee Investment Management LLC 100,000$1,391,0002.19%
BVF INC/IL 575,000$7,998,0001.70%
Aisling Capital LLC 482,680$6,714,0001.59%
Opaleye Management Inc. 146,700$2,041,0001.36%
Broadfin Capital, LLC 803,332$11,174,0001.09%
GENERAL AMERICAN INVESTORS CO INC 477,076$6,636,0000.69%
Opus Point Partners Management, LLC 37,665$524,0000.51%
View complete list of PARATEK PHARMACEUTICALS INC shareholders